We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+6.38%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$400B
AUM Growth
+$29.4B
Cap. Flow
+$10.8B
Cap. Flow %
2.7%
Top 10 Hldgs %
14.74%
Holding
7,051
New
207
Increased
2,867
Reduced
3,206
Closed
165

Sector Composition

Rank Sector Weight
1 Technology 13.16%
2 Healthcare 9.53%
3 Financials 9.25%
4 Consumer Discretionary 7.98%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NM
5651
DELISTED
Navios Maritime Holdings Inc.
NM
$70K ﹤0.01%
9,871
-45,331
-82% -$379K
IDEX
5652
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$70K ﹤0.01%
149
+42
+39% +$16.7K
FCAN
5653
DELISTED
First Trust Canada AlphaDEX Fund
FCAN
$70K ﹤0.01%
2,748
-23,493
-90% -$602K
LFVN icon
5654
LifeVantage
LFVN
$83.4M
$69K ﹤0.01%
6,273
+1,647
+36% +$17.6K
PRPL icon
5655
Purple Innovation
PRPL
$39.3M
$69K ﹤0.01%
474
+101
+27% +$16.4K
CYAN
5656
DELISTED
Cyanotech Corp
CYAN
$68K ﹤0.01%
20,337
CLRB icon
5657
Cellectar Biosciences
CLRB
$20M
$67K ﹤0.01%
75
+73
+3,650% +$86K
CORN icon
5658
Teucrium Corn Fund
CORN
$167M
$67K ﹤0.01%
4,212
-8,426
-67% -$137K
FGNX
5659
FG Nexus Inc
FGNX
$43.1M
$67K ﹤0.01%
80
OPOF
5660
DELISTED
Old Point Financial
OPOF
$67K ﹤0.01%
2,237
-3,836
-63% -$109K
USAS
5661
Americas Gold and Silver
USAS
$1.6B
$67K ﹤0.01%
11,269
+1,767
+19% +$11.2K
WYY icon
5662
WidePoint Corp
WYY
$107M
$66K ﹤0.01%
14,265
-56
-0.4% -$281
AKTS
5663
DELISTED
Akoustis Technologies Inc
AKTS
$66K ﹤0.01%
8,414
-37,107
-82% -$300K
SVA
5664
DELISTED
Sinovac Biotech, Ltd
SVA
$66K ﹤0.01%
8,758
+1,074
+14% +$7.75K
WMCR
5665
DELISTED
Invesco Wilshire Micro-Cap ETF
WMCR
$65K ﹤0.01%
1,744
LRFC
5666
DELISTED
Logan Ridge Finance Corp
LRFC
$64K ﹤0.01%
1,237
-959
-44% -$49.9K
VOC icon
5667
VOC Energy
VOC
$51.7M
$64K ﹤0.01%
11,698
-2,137
-15% -$12.1K
AENZ
5668
DELISTED
Aenza S.A.A.
AENZ
$64K ﹤0.01%
+7,869
New +$78.9K
CIF
5669
DELISTED
MFS Intermediate High Income Fund
CIF
$63K ﹤0.01%
23,950
-494
-2% -$1.28K
MTR
5670
Mesa Royalty Trust
MTR
$5.39M
$63K ﹤0.01%
4,446
+346
+8% +$4.99K
MFV
5671
DELISTED
MFS SPECIAL VALUE TRUST
MFV
$63K ﹤0.01%
11,014
+1,869
+20% +$10.5K
NJV
5672
DELISTED
Nuveen New Jersey Municipal Value Fund Common shares of beneficial interest
NJV
$63K ﹤0.01%
5,003
-73
-1% -$943
INFI
5673
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$62K ﹤0.01%
22,745
+6,027
+36% +$12.5K
MAYS icon
5674
J.W. Mays
MAYS
$61K ﹤0.01%
1,654
RDCM icon
5675
Radcom
RDCM
$164M
$61K ﹤0.01%
+5,414
New +$98.6K

Similar funds

Morgan Stanley's Q3 2018 Portfolio in Review

As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,206 reduced and 165 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
  • Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
  • Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
  • Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
  • Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
  • Morgan Stanley opened 207 new positions and closed 165 in Q3 2018.
  • Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.

Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.